Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC; TRACK-HD Investigators..

Lancet Neurol. 2011 Jan;10(1):31-42. doi: 10.1016/S1474-4422(10)70276-3. Epub 2010 Dec 2.

PMID:
21130037
2.

Huntington's disease.

Ha AD, Fung VS.

Curr Opin Neurol. 2012 Aug;25(4):491-8. doi: 10.1097/WCO.0b013e3283550c97. Review.

PMID:
22772878
3.

Molecular Imaging Markers to Track Huntington's Disease Pathology.

Wilson H, De Micco R, Niccolini F, Politis M.

Front Neurol. 2017 Jan 30;8:11. doi: 10.3389/fneur.2017.00011. eCollection 2017 Jan 30. Review.

4.

Gene therapy in mouse models of huntington disease.

Southwell AL, Patterson PH.

Neuroscientist. 2011 Apr;17(2):153-62. doi: 10.1177/1073858410386236. Review.

5.

The role of immunity in Huntington's disease.

Soulet D, Cicchetti F.

Mol Psychiatry. 2011 Sep;16(9):889-902. doi: 10.1038/mp.2011.28. Epub 2011 Apr 26. Review.

PMID:
21519341
6.

Brain imaging and cognitive dysfunctions in Huntington's disease.

Montoya A, Price BH, Menear M, Lepage M.

J Psychiatry Neurosci. 2006 Jan;31(1):21-9. Review.

7.

PET Imaging in Huntington's Disease.

Roussakis AA, Piccini P.

J Huntingtons Dis. 2015;4(4):287-96. doi: 10.3233/JHD-150171. Review.

8.

Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.

Ross CA, Pantelyat A, Kogan J, Brandt J.

Mov Disord. 2014 Sep 15;29(11):1351-8. doi: 10.1002/mds.26012. Review.

9.

Cognitive impairment in Huntington disease: diagnosis and treatment.

Paulsen JS.

Curr Neurol Neurosci Rep. 2011 Oct;11(5):474-83. doi: 10.1007/s11910-011-0215-x. Review.

10.

Neuroimaging in Huntington's disease.

Niccolini F, Politis M.

World J Radiol. 2014 Jun 28;6(6):301-12. doi: 10.4329/wjr.v6.i6.301. Review.

11.

Current status of PET imaging in Huntington's disease.

Pagano G, Niccolini F, Politis M.

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1171-82. doi: 10.1007/s00259-016-3324-6. Epub 2016 Feb 22. Review.

12.

Brain networks in Huntington disease.

Eidelberg D, Surmeier DJ.

J Clin Invest. 2011 Feb;121(2):484-92. doi: 10.1172/JCI45646. Epub 2011 Feb 1. Review.

13.

Neuroprotection for Huntington's disease: ready, set, slow.

Hersch SM, Rosas HD.

Neurotherapeutics. 2008 Apr;5(2):226-36. doi: 10.1016/j.nurt.2008.01.003. Review.

14.

Huntington disease: natural history, biomarkers and prospects for therapeutics.

Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ.

Nat Rev Neurol. 2014 Apr;10(4):204-16. doi: 10.1038/nrneurol.2014.24. Epub 2014 Mar 11. Review.

PMID:
24614516
15.
16.

Biological Perspectives: Huntington's Disease.

Kowalski PC, Belcher DC, Keltner NL, Dowben JS.

Perspect Psychiatr Care. 2015 Jul;51(3):157-61. doi: 10.1111/ppc.12121. Epub 2015 May 23. Review. No abstract available.

PMID:
26010510
17.

Molecular Imaging of Huntington's Disease.

Ciarmiello A, Giovacchini G, Giovannini E, Lazzeri P, Borsò E, Mannironi A, Mansi L.

J Cell Physiol. 2016 Oct 28. doi: 10.1002/jcp.25666. [Epub ahead of print] Review.

PMID:
27791273

Supplemental Content

Support Center